Universität zu Köln

Schalk, Gesa, Habbig, Sandra, Beck, Bodo B., Licht, Christoph, Hoppe, Bernd and Weber, Lutz T. (2015). Plasmatherapy - Still first line treatment in atypical hemolytic uremic syndrome? Long-term follow-up of four patients. Mol. Immunol., 67 (1). S. 177 - 179. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 0161-5890

Full text not available from this repository.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Schalk, Gesa UNSPECIFIED UNSPECIFIED UNSPECIFIED Habbig, Sandra UNSPECIFIED UNSPECIFIED UNSPECIFIED Beck, Bodo B. UNSPECIFIED UNSPECIFIED UNSPECIFIED Licht, Christoph UNSPECIFIED UNSPECIFIED UNSPECIFIED Hoppe, Bernd UNSPECIFIED UNSPECIFIED UNSPECIFIED Weber, Lutz T. UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-396038
Journal or Publication Title:	Mol. Immunol.
Volume:	67
Number:	1
Page Range:	S. 177 - 179
Date:	2015
Publisher:	PERGAMON-ELSEVIER SCIENCE LTD
Place of Publication:	OXFORD
ISSN:	0161-5890
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language Biochemistry & Molecular Biology; Immunology Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/39603